News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
42 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (5)
2 (321)
3 (345)
4 (310)
5 (394)
6 (122)
7 (3)
8 (3)
9 (242)
10 (360)
11 (259)
12 (398)
13 (145)
14 (4)
15 (16)
16 (326)
17 (318)
18 (251)
19 (262)
20 (127)
21 (4)
22 (5)
23 (228)
24 (302)
25 (222)
26 (289)
27 (144)
28 (1)
29 (3)
30 (42)
31 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Medicure Reports Financial Results for Quarter Ended March 31, 2022 and Appointment of Haaris Uddin as Chief Financial Officer
Medicure Inc. reported its results from operations for the quarter ended March 31, 2022, and is pleased to also announce the appointment of Mr. Haaris Uddin as Chief Financial Officer, effective June 1, 2022.
May 30, 2022
·
12 min read
Drug Development
Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors
Antengene Corporation announced that the first patient has been dosed in the Phase I STAMINA-001 trial to evaluate ATG-037 as a monotherapy or in combination with pembrolizumab in patients with locally advanced or metastatic solid tumors in Australia.
May 30, 2022
·
7 min read
Drug Development
AffaMed Therapeutics Announces First Patient Dosed in the US Phase 1 Clinical Trial of AM712 in Retinal Disease
AffaMed Therapeutics announces that the first patient has been dosed in its US Phase 1 study of AM712, a novel proprietary bispecific biologic molecule blocking both vascular endothelial growth factor and angiopoietin-2 for the treatment of retinal diseases.
May 30, 2022
·
2 min read
Cholinesterase Inhibitors Market Trends and Competitive Landscape Outlook to 2020-2030
Albany NY, United States: Cholinesterase inhibitors, also known as acetylcholine inhibitors, are a group of drugs that are used to prevent the routine breakdown of acetylcholine in the body
May 30, 2022
·
6 min read
Veterinary Tissue Injury Treatment Market Analysis and Opportunity Assessment 2020-2030
Albany NY, United States: Tissue injury, also known as soft tissue injury, is an injury of tendons, muscles, and ligaments across the body.
May 30, 2022
·
5 min read
Tramadol Drug Market Growth, Trends and Demands Research Report and Forecast 2031
Albany NY, United States: Tramadol drug is prescribed to relieve pain in the body; tramadol directly acts on the central nervous system in order help the body relieve pain caused due to a surgery or injury.
May 30, 2022
·
4 min read
Orphan Drugs Market Size, Shares and Trends | Growth Drivers | Forecast [2020-2030]
The size of the orphan drugs market has been estimated to grow at a significant speed in the forthcoming years.
May 30, 2022
·
6 min read
Drug Development
Pharnext Announces On-Schedule Completion of Patient Enrollment in its Pivotal Phase III Trial of PXT3003, the PREMIER Trial, for the Treatment of Charcot-Marie-Tooth Disease Type 1A
Pharnext SA announces it has completed the enrollment of 387 patients in its pivotal Phase III clinical study of PXT3003, the PREMIER trial, in Charcot-Marie-Tooth disease type 1A.
May 30, 2022
·
6 min read
The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures
Zelixir Biotech announces it has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes amid the recent emergence of monkeypox cases in Europe and the United States.
May 30, 2022
·
2 min read
Drug Development
Abu Dhabi Stem Cells Center to begin phase 1/2 trial of game-changing multiple sclerosis treatment
Abu Dhabi Stem Cells Center, a leading research institute in Abu Dhabi, will begin a ground-breaking clinical trial to help treat multiple sclerosis.
May 30, 2022
·
3 min read
Previous
2 of 5
Next